Author

Haruhiko Kobashi

Observed names: H KOBASHI, H Kobashi, H. KOBASHI, H. Kobashi, HARUHIKO KOBASHI, Haruhiko KOBASHI, Kobashi, H., 小橋晴彦

Institution: Okayama Red Cross General Hospital

Observed institutions: Oslo University Hospital, Kyushu University, Okayama University, Kawasaki Medical School, Eulji University, Japanese Red Cross Society, Japan, Kyoto Prefectural University of Medicine, Fukuyama City Hospital, Tsuyama Chuo Hospital, Okayama Red Cross General Hospital, Nagasaki Medical Center, Kinki Central Hospital, Kawasaki Hospital, Kyoto Katsura Hospital, Shikoku Cancer Center, Tokyo Shinagawa Hospital, Toranomon Hospital, Technical University of Munich

ORCID: 0000-0003-4313-6808

Observed ORCID: 0000-0003-4313-6808

OpenAlex ID: A5046992544

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C†

2005 · Yoshiaki Iwasaki, Hiroshi Ikeda, et al. · Hepatology · 170

PDF

Sepsis‐associated liver injury: Incidence, classification and the clinical significance

2012 · Haruhiko Kobashi, Junichi Toshimori, et al. · Hepatology Research · 141

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma

2011 · Haruhiko Yoshida, Yasushi Shiratori, et al. · Hepatology · 128

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

2010 · Osamu Yokosuka, Koichi Takaguchi, et al. · Journal of Hepatology · 123

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

2005 · Yasuhiro Miyake, Yoshiaki Iwasaki, et al. · Journal of Hepatology · 97

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

2019 · Masaki Maeda, Issei Saeki, et al. · Liver Cancer · 77

Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver

1994 · Minoru Tomita, Kazuhide Yamamoto, et al. · Hepatology · 77

PDF

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

2004 · Yoshiaki Iwasaki, Kouichi Takaguchi, et al. · Liver International · 68

Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

2009 · Yasuhiro Miyake, Haruhiko Kobashi, et al. · Journal of Gastroenterology · 66

Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort.

2005 · Cheng-Yu Piao, Shin-ichi Fujioka, et al. · PubMed · 66

Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis

2006 · Y. MIYAKE, Y. IWASAKI, et al. · Alimentary Pharmacology & Therapeutics · 62

Autoimmune hepatitis with acute presentation in Japan

2009 · Y. Miyake, Y. Iwasaki, et al. · Digestive and Liver Disease · 59

Lamivudine Treatment Improves the Prognosis of Fulminant Hepatitis B

2008 · Yasuhiro Miyake, Yoshiaki Iwasaki, et al. · Internal Medicine · 56

PDF

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

2021 · Kaoru Tsuchiya, Masayuki Kurosaki, et al. · Cancers · 54

PDF

Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival

2006 · Hironori Tanaka, Kazuhiro Nouso, et al. · Liver International · 52

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

2022 · Hironori Ochi, Masayuki Kurosaki, et al. · Hepatology Research · 51

PDF

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

2020 · Nobuharu Tamaki, Masayuki Kurosaki, et al. · Clinical Infectious Diseases · 45

PDF

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

2018 · Keiji Tsuji, Masayuki Kurosaki, et al. · Journal of Gastroenterology · 45

Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

2011 · Haruhiko Kobashi, Yasuhiro Miyake, et al. · Hepatology Research · 45

Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid

2011 · Yasuto Takeuchi, Fusao Ikeda, et al. · Journal of Gastroenterology and Hepatology · 42

Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure

2016 · Jun Itakura, Masayuki Kurosaki, et al. · PLoS ONE · 40

Serum levels of platelet‐derived growth factor‐BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure

2010 · Hiroki Takayama, Yasuhiro Miyake, et al. · Journal of Gastroenterology and Hepatology · 38

PDF

Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group

2009 · Yasuhiro Miyake, Yoshiaki Iwasaki, et al. · Digestive and Liver Disease · 38

Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis

2007 · Yasuhiro Miyake, Yoshiaki Iwasaki, et al. · Hepatology Research · 38

Clinical Features of Japanese Elderly Patients with Type 1 Autoimmune Hepatitis

2007 · Yasuhiro Miyake, Yoshiaki Iwasaki, et al. · Internal Medicine · 36

PDF

Works count: 151

Citation count: 2,830

H-index: 30

I10-index: 69